1. Task Force on Tardive Dyskinesia. Tardive dyskinesia: a task force report of the American
Psychiatric Association. 1992.
2. Cloud LJ, Zutshi D, Factor SA. Tardive dyskinesia: therapeutic options for an increasingly
common disorder. Neurotherapeutics. 2014;11(1):166-176. doi:10.1007/s13311-013-0222-5
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed.,
text revision. American Psychiatric Association; 2023.
4. Guy W. ECDEU Assessment Manual for Psychopharmacology. National Institute of Mental
Health; 1976.
5. Caroff SN, Hurford I, Lybrand J, Campbell EC. Movement disorders induced by antipsychotic
drugs: implications of the CATIE schizophrenia trial. Neurol Clin. 2011;29(1):127-148, viii.
6. Kenney C, Hunter C, Davidson A, Jankovic J. Metaclopramide, an increasingly recognized cause
of tardive dyskinesia. J Clin Pharmacol. 2008;48(3):379-384. doi:10.1177/0091270007312258
7. Sanger GJ, Andrews PLR. A history of drug discovery for treatment of nausea and vomiting and
the implications for future research. Front. Pharmacol. 2018;9:913. doi:10.3389/fphar.2018.00913
8. Data on file. Neurocrine Biosciences, Inc.
9. Carbon M, Hsieh CH, Kane JM, Correll CU. Tardive dyskinesia prevalence in the period of
second-generation antipsychotic use: a meta-analysis. J Clin Psychiatry. 2017;78(3):e264–e278.
doi: 10.4088/JCP.16r10832
10. Ascher-Svanum H, Zhu B, Faries D, Peng X, Kinon BJ, Tohen M. Tardive dyskinesia and the 3-
year course of schizophrenia: results from a large, prospective, naturalistic study. J Clin
Psychiatry. 2008;69(10):1580-1588. doi:10.4088/jcp.v69n1008
11. National Alliance for Mental Illness. Mental health by the numbers. Accessed January 27, 2021.
12. Reinert M, Fritze D, Nguyen T. The state of mental health in America 2023. Mental Health
America; 2022.
13. Boumans CE, de Mooij KJ, Koch PA, van ‘t Hof MA, Zitman FG. Is the social acceptability of
psychiatric patients decreased by orofacial dyskinesia? Schizophr Bull. 1994;20(2):339-344.
14. Yassa R. Functional impairment in tardive dyskinesia: medical and psychosocial dimensions.
Acta Psychiatr Scand. 1989;80(1):64-67. doi:10.1111/j.1600-0447.1989.tb01301.x.
15. Citrome L. Clinical management of tardive dyskinesia: five steps to success. J Neurol Sci.
2017;383:199-204. doi:10.1016/j.jns.2017.11.019